Aarti Pharmalabs Limited Stock Forecast
Aarti Pharmalabs Limited stock price up 0.93% on Tuesday
(Updated on Jun 25, 2024)
The Aarti Pharmalabs Limited stock price gained 0.93% on the last trading day (Tuesday, 25th Jun 2024), rising from ₹623.40 to ₹629.20. During the last trading day the stock fluctuated 3.18% from a day low at ₹615.20 to a day high of ₹634.75. The price has been going up and down for this period, and there has been a 4.58% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 thousand more shares were traded than the day before. In total, 129 thousand shares were bought and sold for approximately ₹81.41 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.50% during the next 3 months and, with a 90% probability hold a price between ₹664.42 and ₹743.82 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
AARTIPHARM.NS Signals & Forecast
The Aarti Pharmalabs Limited stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately ₹629.34. On a fall, the stock will find some support from the long-term average at approximately ₹597.50. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 18, 2024, and so far it has fallen -2.25%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Aarti Pharmalabs Limited stock
On the downside, the stock finds support just below today's level from accumulated volume at ₹577.35 and ₹575.45. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aarti Pharmalabs Limited finds support just below today's level at ₹577.35. If this is broken, then the next support from accumulated volume will be at ₹575.45 and ₹541.65.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved ₹19.55 between high and low, or 3.18%. For the last week, the stock has had daily average volatility of 3.51%.
Our recommended stop-loss: ₹603.87 (-4.03%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 78 and this increases the risk substantially. There is a sell signal from a pivot top found 7 days ago.)
Trading Expectations (AARTIPHARM.NS) For The Upcoming Trading Day Of Wednesday 26th
For the upcoming trading day on Wednesday, 26th we expect Aarti Pharmalabs Limited to open at ₹626.38, and during the day (based on 14 day Average True Range), to move between ₹604.35 and ₹654.05, which gives a possible trading interval of +/-₹24.85 (+/-3.95%) up or down from last closing price. If Aarti Pharmalabs Limited takes out the full calculated possible swing range there will be an estimated 7.90% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at ₹633.35 (0.66%) than the support at ₹577.35 (8.24%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Aarti Pharmalabs Limited stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Aarti Pharmalabs Limited stock to perform well in the short-term.
Current score: 1.273 Buy Candidate Unchanged
Predicted Opening Price for Aarti Pharmalabs Limited of Wednesday, June 26, 2024
Fair opening price June 26, 2024 | Current price |
---|---|
₹626.38 ( 0.448%) | ₹629.20 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for AARTIPHARM.NS
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 645.93 | 2.66% |
R2 | 638.47 | 1.47% |
R1 | 633.85 | 0.739% |
Price | 629.20 | |
S1 | 618.92 | -1.63% |
S2 | 614.30 | -2.37% |
S3 | 606.83 | -3.55% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 643.70 | 2.30% |
R2 | 640.15 | 1.74% |
R1 | 633.35 | 0.660% |
Price | 629.20 | |
S1 | 577.35 | -8.24% |
S2 | 575.45 | -8.54% |
S3 | 541.65 | -13.91% |
AARTIPHARM Dividend Payout History
# | Ex-Date | Pay Date | Amount | Yield | |
---|---|---|---|---|---|
1 | Feb 19, 2024 | Feb 19, 2024 | Mar 08, 2024 | ₹2.00 | 0.439% |
FAQ
Click here for our free guide on how to buy Aarti Pharmalabs Limited Stock.